Go Pro

Merit Medical Systems (MMSI) Competitors

Merit Medical Systems logo
$69.45 +0.11 (+0.16%)
Closing price 07/1/2026 04:00 PM Eastern
Extended Trading
$69.42 -0.03 (-0.05%)
As of 08:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MMSI vs. ADUS, HQY, MEDP, AMN, and ELV

Should you buy Merit Medical Systems stock or one of its competitors? MarketBeat compares Merit Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Merit Medical Systems include Addus HomeCare (ADUS), HealthEquity (HQY), Medpace (MEDP), AMN Healthcare Services (AMN), and Elevance Health (ELV). These companies are all part of the "medical" sector.

How does Merit Medical Systems compare to Addus HomeCare?

Merit Medical Systems (NASDAQ:MMSI) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Merit Medical Systems has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.54B2.69$128.49M$2.3130.06
Addus HomeCare$1.45B1.32$95.91M$5.4118.90

Merit Medical Systems has a net margin of 9.03% compared to Addus HomeCare's net margin of 6.89%. Merit Medical Systems' return on equity of 13.54% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
Addus HomeCare 6.89%9.80%7.34%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Merit Medical Systems currently has a consensus price target of $92.80, indicating a potential upside of 33.62%. Addus HomeCare has a consensus price target of $131.00, indicating a potential upside of 28.12%. Given Merit Medical Systems' higher probable upside, equities analysts plainly believe Merit Medical Systems is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Addus HomeCare
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70

In the previous week, Merit Medical Systems had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 5 mentions for Merit Medical Systems and 3 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.83 beat Merit Medical Systems' score of 1.49 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Merit Medical Systems has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market.

Summary

Merit Medical Systems beats Addus HomeCare on 11 of the 17 factors compared between the two stocks.

How does Merit Medical Systems compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

HealthEquity has a net margin of 17.25% compared to Merit Medical Systems' net margin of 9.03%. HealthEquity's return on equity of 14.75% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.25% 14.75% 9.22%
Merit Medical Systems 9.03%13.54%7.94%

In the previous week, HealthEquity had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 6 mentions for HealthEquity and 5 mentions for Merit Medical Systems. HealthEquity's average media sentiment score of 1.61 beat Merit Medical Systems' score of 1.49 indicating that HealthEquity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Merit Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

HealthEquity presently has a consensus target price of $110.57, indicating a potential upside of 19.81%. Merit Medical Systems has a consensus target price of $92.80, indicating a potential upside of 33.62%. Given Merit Medical Systems' higher possible upside, analysts plainly believe Merit Medical Systems is more favorable than HealthEquity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.86
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

HealthEquity has higher earnings, but lower revenue than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B5.87$215.20M$2.6734.57
Merit Medical Systems$1.54B2.69$128.49M$2.3130.06

HealthEquity has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

HealthEquity beats Merit Medical Systems on 13 of the 17 factors compared between the two stocks.

How does Merit Medical Systems compare to Medpace?

Merit Medical Systems (NASDAQ:MMSI) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

Medpace has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.54B2.69$128.49M$2.3130.06
Medpace$2.68B5.80$451.12M$15.9134.17

Medpace has a net margin of 17.19% compared to Merit Medical Systems' net margin of 9.03%. Medpace's return on equity of 120.89% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.03% 13.54% 7.94%
Medpace 17.19%120.89%24.79%

Merit Medical Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

In the previous week, Merit Medical Systems had 3 more articles in the media than Medpace. MarketBeat recorded 5 mentions for Merit Medical Systems and 2 mentions for Medpace. Merit Medical Systems' average media sentiment score of 1.49 beat Medpace's score of 0.74 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 20.5% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Merit Medical Systems presently has a consensus target price of $92.80, suggesting a potential upside of 33.62%. Medpace has a consensus target price of $467.08, suggesting a potential downside of 14.07%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Merit Medical Systems is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Medpace
1 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

Medpace beats Merit Medical Systems on 10 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

AMN Healthcare Services currently has a consensus target price of $27.00, suggesting a potential downside of 19.10%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 33.62%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

AMN Healthcare Services has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.03% compared to AMN Healthcare Services' net margin of -0.95%. AMN Healthcare Services' return on equity of 18.01% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services-0.95% 18.01% 5.19%
Merit Medical Systems 9.03%13.54%7.94%

In the previous week, AMN Healthcare Services had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 6 mentions for AMN Healthcare Services and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.49 beat AMN Healthcare Services' score of 0.35 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
0 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Merit Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.47-$95.70M-$0.87N/A
Merit Medical Systems$1.54B2.69$128.49M$2.3130.06

Summary

Merit Medical Systems beats AMN Healthcare Services on 12 of the 16 factors compared between the two stocks.

How does Merit Medical Systems compare to Elevance Health?

Elevance Health (NYSE:ELV) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Merit Medical Systems. Elevance Health is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$200.42B0.45$5.66B$23.5117.67
Merit Medical Systems$1.54B2.69$128.49M$2.3130.06

Elevance Health currently has a consensus target price of $416.11, suggesting a potential upside of 0.14%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 33.62%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
9 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.61
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

In the previous week, Elevance Health had 19 more articles in the media than Merit Medical Systems. MarketBeat recorded 24 mentions for Elevance Health and 5 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.49 beat Elevance Health's score of 1.33 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
10 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a net margin of 9.03% compared to Elevance Health's net margin of 2.62%. Elevance Health's return on equity of 15.58% beat Merit Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.62% 15.58% 5.57%
Merit Medical Systems 9.03%13.54%7.94%

Elevance Health has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Summary

Merit Medical Systems beats Elevance Health on 9 of the 16 factors compared between the two stocks.

Get Merit Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MMSI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MMSI vs. The Competition

MetricMerit Medical SystemsMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$4.14B$16.28B$6.79B$12.60B
Dividend YieldN/A1.33%2.66%6.14%
P/E Ratio30.0719.0227.4325.27
Price / Sales2.692.40537.9499.25
Price / Cash11.8014.1047.9959.26
Price / Book2.603.3811.026.62
Net Income$128.49M$534.24M$3.57B$336.83M
7 Day Performance-1.95%-0.16%2.90%3.25%
1 Month Performance14.06%5.78%3.71%0.92%
1 Year Performance-25.73%1.17%34.39%27.62%

Merit Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MMSI
Merit Medical Systems
4.3524 of 5 stars
$69.45
+0.2%
$92.80
+33.6%
-26.1%$4.14B$1.54B30.077,500
ADUS
Addus HomeCare
4.2601 of 5 stars
$95.03
+0.8%
$131.00
+37.9%
-9.5%$1.76B$1.45B17.5750,659
HQY
HealthEquity
4.2958 of 5 stars
$84.61
-0.7%
$110.57
+30.7%
-10.3%$7.12B$1.31B31.692,814
MEDP
Medpace
1.9683 of 5 stars
$455.66
-1.0%
$467.08
+2.5%
+69.3%$13.14B$2.68B28.646,200
AMN
AMN Healthcare Services
1.7123 of 5 stars
$30.40
-1.9%
$25.29
-16.8%
+51.7%$1.20B$2.73BN/A2,664

Related Companies and Tools


This page (NASDAQ:MMSI) was last updated on 7/2/2026 by MarketBeat.com Staff.
From Our Partners